证券之星消息，截至2026年2月3日收盘，朗玛信息(300288)报收于14.57元，上涨2.17%，换手率 3.88%，成交量9.95万手，成交额1.43亿元。 2月3日的资金流向数据方面，主力资金净流出206.59万元，占总成交额1.44%，游资资金净流出554.75 万元，占总成交额3.87%，散户资金净流入761.34万元，占总成交额5.31%。 近5日资金流向一览见下表： 注：主力资金为特大单成交，游资为大单成交，散户为中小单成交 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 朗玛信息2025年三季报显示，前三季度公司主营收入2.24亿元，同比下降24.75%；归母净利润1350.7万 元，同比下降67.04%；扣非净利润1300.73万元，同比下降67.9%；其中2025年第三季度，公司单季度主 营收入7252.69万元，同比下降36.46%；单季度归母净利润-92.85万元，同比下降105.48%；单季度扣非 净利润-85.34万元，同比下降105.01%；负债率17.27%，投资收益1699.59万元，财务费用-2 ...

证券日报网讯2月3日，朗玛信息（300288）在互动平台回答投资者提问时表示，截至2026年1月30日， 公司股东人数为36092户。 ...

Group 1 - The company, Langma Information (300288), announced an expected net profit attributable to shareholders for the year 2025, ranging from 10 million to 14.5 million yuan [1]

Company Overview - The company operates in two main business segments: medical services and internet medical services, as well as telecommunications and value-added telecommunications services [6] - The company plans to recognize an impairment of goodwill amounting to approximately 3.6 million yuan due to a continuous decline in revenue from its wholly-owned subsidiary, Guangzhou Qisheng Information Technology Co., Ltd [6] Financial Performance - The company's medical information service business and mobile resale business experienced a revenue decline compared to the same period last year due to changes in market demand [6] - Excluding the impact of goodwill impairment, the company's financial department estimates that the net profit attributable to shareholders for the year 2025 is expected to be between 13 million yuan and 18 million yuan [6] Profitability Metrics - The historical net profit and non-recurring net profit growth rates are presented, indicating fluctuations in profitability over the years [8] - The company’s net profit and non-recurring net profit figures are shown in billions, with specific quarterly changes highlighted [8]

每经AI快讯，朗玛信息1月30日晚间发布业绩预告，预计2025年归属于上市公司股东的净利润1000万元 ~1450万元，同比扭亏为盈。2024年度由于公司对收购全资子公司广州启生信息技术有限公司100%股权 形成的商誉所在资产组计提商誉减值准备约5.66亿元，造成公司合并口径归属于上市公司股东的净利润 产生亏损约5.12亿元。本报告期，由于启生信息业务收入呈持续下滑趋势，结合对启生信息未来经营业 绩、盈利能力的分析，出于谨慎性原则，判断相关资产组商誉发生继续减值迹象，公司本期拟计提商誉 减值准备约360万元。最终商誉减值准备计提金额，将在公司聘请的具备证券期货从业资格的评估机构 及审计机构进行评估和审计的基础上，由公司履行内部的相关程序后确定。 每经头条（nbdtoutiao）——核电建设热潮下，设备厂忙到"飞起"！订单已排至2028年，员工三班倒， 产线24小时不停 免责声明：本文内容与数据仅供参考，不构成投资建议，使用前请核实。据此操作，风险自担。 每日经济新闻 （记者 王晓波） ...

Core Viewpoint - The company, Langma Information, has released its performance forecast for 2025, expecting a net profit attributable to shareholders of between 10 million and 14.5 million yuan, with a net profit excluding non-recurring gains and losses estimated between 6.5 million and 9.5 million yuan [1] Group 1: Performance Forecast - The company anticipates a net profit of 10 million to 14.5 million yuan for 2025, with a net profit excluding non-recurring items projected at 6.5 million to 9.5 million yuan [1] - The financial department estimates that, excluding goodwill impairment, the net profit for 2025 could range from 13 million to 18 million yuan [1] Group 2: Reasons for Performance Changes - In 2024, the company recorded a goodwill impairment of 56.648 million yuan due to the acquisition of its wholly-owned subsidiary, Guangzhou Qisheng Information Technology Co., Ltd., leading to a net loss of 51.20997 million yuan [1] - The decline in revenue from the medical information services operated by Qisheng Information and the mobile resale business of its subsidiary, Guiyang Langma Communication Technology Co., Ltd., was influenced by changes in market demand [1] - The company plans to recognize an additional goodwill impairment of approximately 3.6 million yuan based on cautious assessment of future performance and profitability of the related asset group [1] Group 3: Strategic Adjustments - The company is actively adjusting its development strategy, focusing on the research and development of medical artificial intelligence technologies and products [1] - The "39AI Doctor" has been launched, featuring modules for disease diagnosis, case analysis, doctor notes, medical consultations, and voice quick inquiries, targeting the TOB market for medical institutions [1] - The company is implementing strict cost control measures and optimizing its business structure to enhance profitability [1] Group 4: Non-Recurring Gains and Losses - The impact of non-recurring gains and losses on the company's net profit for the current period is estimated to be around 4.29 million yuan, compared to 6.27 million yuan in the same period last year [1]

朗玛信息公告，预计2025年度净利润为1000万元-1450万元，上年同期亏损5.12亿元。预计扣除非经常 性损益后的净利润为650万元-950万元，上年同期亏损5.18亿元。2024年度由于公司对收购全资子公司 广州启生信息技术有限公司（以下简称"启生信息"）100%股权形成的商誉所在资产组计提商誉减值准 备5.66亿元，造成公司合并口径归属于上市公司股东的净利润产生亏损5.12亿元。 ...

Financial Performance - The company expects a net profit of between 1,000 and 1,450 million yuan for 2025, indicating a turnaround from a loss of 51,209.97 million yuan in the previous year[3] - The net profit after deducting non-recurring gains and losses is projected to be between 650 and 950 million yuan, compared to a loss of 51,837.21 million yuan last year[3] - The impact of non-recurring gains and losses on the current net profit is estimated to be around 4.29 million yuan, down from 6.27 million yuan in the previous year[6] Business Strategy - The company is actively adjusting its development strategy, focusing on medical artificial intelligence technology research and product development, with the "39AI Doctor" platform now offering various functionalities[6] - The company aims to promote its products primarily to the B2B market, targeting medical institutions[6] - Cost control measures and optimization of business structure are being implemented to enhance profitability[6] Goodwill Impairment - The company plans to recognize an additional goodwill impairment of approximately 3.6 million yuan due to ongoing declines in the business income of its subsidiary, Qisheng Information[6] Reporting Schedule - The company has scheduled the disclosure of its 2025 annual report for April 28, 2026, where detailed business data will be provided[7]

证券之星消息，截至2026年1月23日收盘，朗玛信息(300288)报收于15.08元，上涨1.62%，换手率 3.77%，成交量9.67万手，成交额1.45亿元。 1月23日的资金流向数据方面，主力资金净流入710.35万元，占总成交额4.9%，游资资金净流出467.23 万元，占总成交额3.22%，散户资金净流出243.12万元，占总成交额1.68%。 近5日资金流向一览见下表： 该股主要指标及行业内排名如下： 朗玛信息2025年三季报显示，前三季度公司主营收入2.24亿元，同比下降24.75%；归母净利润1350.7万 元，同比下降67.04%；扣非净利润1300.73万元，同比下降67.9%；其中2025年第三季度，公司单季度主 营收入7252.69万元，同比下降36.46%；单季度归母净利润-92.85万元，同比下降105.48%；单季度扣非 净利润-85.34万元，同比下降105.01%；负债率17.27%，投资收益1699.59万元，财务费用-252.96万元， 毛利率29.25%。朗玛信息（300288）主营业务：医疗服务+互联网医疗业务包括实体医疗机构业务、医 疗信息服务业务、互联网医院业务 ...

Core Viewpoint - The company emphasizes its commitment to comply with information disclosure regulations and will fulfill its obligations regarding performance forecasts when necessary [1] Group 1 - The company stated that it will disclose its 2025 annual report in due time, providing insights into its operational performance for that year [1]